| Sarah Dunn Treter, MD | |
|
44 S Washington Ave, Greensburg, PA 15601-2768 | |
| (724) 689-1335 | |
| (724) 689-1337 |
| Full Name | Sarah Dunn Treter |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 20 Years |
| Location | 44 S Washington Ave, Greensburg, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518104207 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MD449071 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Excela Health Home Care & Hospice | Greensburg, PA | Home health agency |
| Excela Health Westmoreland Regional Hospital | Greensburg, PA | Hospital |
| Excela Health Latrobe Hospital | Latrobe, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Excela Health Physician Practices, Inc | 6204737117 | 438 |
News Archive
A family of proteins that help cancer cells survive and spread around the body may be associated with improved prognosis for some women receiving treatment for breast cancer, research has shown.
Dilon Technologies, Inc., the leader in molecular breast imaging, today announced the release of the newest Dilon 6800 Software update including enhancements for both breast and general nuclear medicine applications image processing. The new software functionalities complement the Slant15 Collimator for breast imaging and the Low Energy High-Resolution (LEHR) Collimator for general nuclear medicine applications, both released earlier this year as purchase options for the Dilon 6800 gamma camera.
Staff at the University of Liverpool's Department of Eye & Vision Science have been awarded £1.3 million by the National Institute for Health Research's Intervention for Innovation (i4i) program to develop a state-of-the-art Ultra-Sensitive Optical Coherence Tomography system.
Giving birth in an alternative setting within a hospital like a bed-free birthing room or one designed to be "homelike" is just as safe for healthy women as laboring in a traditional hospital bed and women who use these rooms are nearly twice as likely to be satisfied with their birth experiences, according to an updated Cochrane review.
A new drug may help cancer patients mobilize the cells necessary to restore their blood-forming system after high-dose chemotherapy, according to results from a clinical trial at the Kimmel Cancer Center at Thomas Jefferson University Hospital in Philadelphia and at other centers across the nation.
› Verified 6 days ago
| Entity Name | Excela Health Physician Practices, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821225202 PECOS PAC ID: 6204737117 Enrollment ID: O20040322001393 |
News Archive
A family of proteins that help cancer cells survive and spread around the body may be associated with improved prognosis for some women receiving treatment for breast cancer, research has shown.
Dilon Technologies, Inc., the leader in molecular breast imaging, today announced the release of the newest Dilon 6800 Software update including enhancements for both breast and general nuclear medicine applications image processing. The new software functionalities complement the Slant15 Collimator for breast imaging and the Low Energy High-Resolution (LEHR) Collimator for general nuclear medicine applications, both released earlier this year as purchase options for the Dilon 6800 gamma camera.
Staff at the University of Liverpool's Department of Eye & Vision Science have been awarded £1.3 million by the National Institute for Health Research's Intervention for Innovation (i4i) program to develop a state-of-the-art Ultra-Sensitive Optical Coherence Tomography system.
Giving birth in an alternative setting within a hospital like a bed-free birthing room or one designed to be "homelike" is just as safe for healthy women as laboring in a traditional hospital bed and women who use these rooms are nearly twice as likely to be satisfied with their birth experiences, according to an updated Cochrane review.
A new drug may help cancer patients mobilize the cells necessary to restore their blood-forming system after high-dose chemotherapy, according to results from a clinical trial at the Kimmel Cancer Center at Thomas Jefferson University Hospital in Philadelphia and at other centers across the nation.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Dunn Treter, MD 44 S Washington Ave, Greensburg, PA 15601-2768 Ph: (724) 689-1335 | Sarah Dunn Treter, MD 44 S Washington Ave, Greensburg, PA 15601-2768 Ph: (724) 689-1335 |
News Archive
A family of proteins that help cancer cells survive and spread around the body may be associated with improved prognosis for some women receiving treatment for breast cancer, research has shown.
Dilon Technologies, Inc., the leader in molecular breast imaging, today announced the release of the newest Dilon 6800 Software update including enhancements for both breast and general nuclear medicine applications image processing. The new software functionalities complement the Slant15 Collimator for breast imaging and the Low Energy High-Resolution (LEHR) Collimator for general nuclear medicine applications, both released earlier this year as purchase options for the Dilon 6800 gamma camera.
Staff at the University of Liverpool's Department of Eye & Vision Science have been awarded £1.3 million by the National Institute for Health Research's Intervention for Innovation (i4i) program to develop a state-of-the-art Ultra-Sensitive Optical Coherence Tomography system.
Giving birth in an alternative setting within a hospital like a bed-free birthing room or one designed to be "homelike" is just as safe for healthy women as laboring in a traditional hospital bed and women who use these rooms are nearly twice as likely to be satisfied with their birth experiences, according to an updated Cochrane review.
A new drug may help cancer patients mobilize the cells necessary to restore their blood-forming system after high-dose chemotherapy, according to results from a clinical trial at the Kimmel Cancer Center at Thomas Jefferson University Hospital in Philadelphia and at other centers across the nation.
› Verified 6 days ago
Dr. Arshad Malik Bachelani, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 44 S Washington Ave, Greensburg, PA 15601 Phone: 724-689-1335 Fax: 724-689-1337 | |
Jodi M Telli, PA-C Surgery Medicare: Accepting Medicare Assignments Practice Location: 44 S Washington Ave, Greensburg, PA 15601 Phone: 724-689-1335 Fax: 724-689-1337 | |
Mr. Francis Regis Johns Jr., M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 6154 State Route 30, Suite 100, Greensburg, PA 15601 Phone: 724-830-9305 Fax: 724-830-9356 | |
Dr. John Domit, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 532 W Pittsburgh St, Greensburg, PA 15601 Phone: 724-832-4450 Fax: 724-830-6669 | |
Dr. Mark A. Zelkovic, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 530 South St, Suite 300, Greensburg, PA 15601 Phone: 724-850-3142 Fax: 724-850-3143 | |
Paul Malaspina, Surgery Medicare: Accepting Medicare Assignments Practice Location: 44 S Washington Ave, Greensburg, PA 15601 Phone: 724-689-1335 Fax: 724-689-1337 |